Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nebbad

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Medecine Et Maladies Infectieuses|October 10, 2006
[Optimal vancomycin serum level in Staphylococcus aureus infections?]E Bingen, P Mariani-Kurkdjian, B Nebbad
Infectious Diseases Now|March 8, 2022
Tuberculosis in sickle cell disease patientsA-L Houist, C Lafont, C Gomart, et al.
The Journal of Hospital Infection|October 12, 2016
First nosocomial outbreak of vanA-type vancomycin-resistant Enterococcus raffinosus in FranceS Jolivet, M Fines-Guyon, B Nebbad, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coliH Guet-Revillet, A Emirian, M Groh, et al.
Journal of Medical Microbiology|October 12, 2018
Are bacterial culture quantifications reliable? Comparative performance of the WASP automated inoculation instrument in the era of ISO 15189 accreditationV Fihman, S C Bleunven, J M Le Glaunec, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2018
Coagulase-negative staphylococci are associated to the mild inflammatory pattern of healthcare-associated meningitis: a retrospective studyS Couffin, D Lobo, F Cook, et al.
New Microbes and New Infections|March 11, 2015
Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and BC Eckert, A Emirian, A Le Monnier, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Medecine Et Maladies Infectieuses|October 10, 2006
[Optimal vancomycin serum level in Staphylococcus aureus infections?]E Bingen, P Mariani-Kurkdjian, B Nebbad
Infectious Diseases Now|March 8, 2022
Tuberculosis in sickle cell disease patientsA-L Houist, C Lafont, C Gomart, et al.
The Journal of Hospital Infection|October 12, 2016
First nosocomial outbreak of vanA-type vancomycin-resistant Enterococcus raffinosus in FranceS Jolivet, M Fines-Guyon, B Nebbad, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coliH Guet-Revillet, A Emirian, M Groh, et al.
Journal of Medical Microbiology|October 12, 2018
Are bacterial culture quantifications reliable? Comparative performance of the WASP automated inoculation instrument in the era of ISO 15189 accreditationV Fihman, S C Bleunven, J M Le Glaunec, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2018
Coagulase-negative staphylococci are associated to the mild inflammatory pattern of healthcare-associated meningitis: a retrospective studyS Couffin, D Lobo, F Cook, et al.
New Microbes and New Infections|March 11, 2015
Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and BC Eckert, A Emirian, A Le Monnier, et al.
Pageof 1